Ophthalmology Doctors in Hilo, HI Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Nancy Wilson Lundblad, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1178 Kinoole St Ste A, Hilo, HI 96720 Phone: 808-969-1470

Dr. William T. Perryman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1178a Kinoole St, Hilo, HI 96720 Phone: 808-969-1419    Fax: 808-969-1297

Rick A Carpenter, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 Aupuni St Ste 101, Hilo, HI 96720 Phone: 808-935-2964    Fax: 808-961-6421

Dr. Michael James Miyashiro, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 47 Lanihuli Street, Hilo, HI 96720 Phone: 808-961-4711    Fax: 808-969-3343

Daniel Beam Driscoll, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 76 Kalanianaole Ave, Hilo, HI 96720 Phone: 808-333-3233    Fax: 808-315-7663

News Archive

New gold nanoparticle method allows for tracking studies of virus pathways in tissues

Enteroviruses are pathogenic viruses infecting humans. This group consists of polioviruses, coxsackieviruses, echoviruses and rhinoviruses. Enteroviruses are the most common causes of flu, but they also cause serious symptoms such as heart muscle infections and paralysis. Recently, enteroviruses have been linked with chronic diseases such as diabetes.

Specific factors affect smoking patterns in diverse populations

Asian-American youth are one of the fastest growing populations in the United States. Although Asian Americans begin smoking later in life, they are more likely to smoke regularly and at a higher rate than other ethnic or racial groups, according to the Department of Health and Human Services. Now, a University of Missouri researcher is examining the unique differences in adolescent tobacco use among Asians and other groups to provide specific recommendations for prevention and treatment.

Trius Therapeutics awarded $28 million to develop novel drugs targeting bacterial DNA Gyrase and Topoisomerase IV

Trius Therapeutics, Inc., today announced the award of a $28 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the development of novel antibiotics directed against multiple Gram-negative bacterial pathogens.

San Diego's PACE program lowering cost for seniors who want to retain independence

The San Diego Union-Tribune reports that an elderly care program is allowing senior citizens to retain their independence by providing medical care and home assistance through a nonprofit program.

Read more Medical News

› Verified 3 days ago